MGC Pharma's breakthrough in epilepsy treatment with CannEpil is now available in the UK. This high-CBD, low-THC formulation is part of a pioneering approach to refractory epilepsy treatment. Learn how MGC Pharma is transforming patient care a
The 2023 Global Culture Report by O.C. Tanner reveals that a poor work-life balance and a lack of staff recognition are key factors driving physical and emotional distress among pharmaceutical industry employees.
MGC Pharmaceuticals' Malta facility has received formal EU-Good Manufacturing Practice (GMP) certification, enabling the production of high-quality plant-inspired medicines such as CannEpil and CimetrA. The large-scale facility can produce over 20
EntityRisk announced that Jeffrey B. Kindler and Frank D’Amelio have led a Series A investment in the company and have been appointed to EntityRisk’s board of directors.
Bluepharma, a Portuguese pharmaceutical company, has opened an industrial unit specialising in the production of oral solid high-potent drugs, namely in the oncology area.
Berry Global Healthcare is introducing a comprehensive bundle solution to help customers capitalise on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharma and herbal market for syrup and liquid medicines.
Nearly half of senior decision-makers working for drug development companies or manufacturers said data silos derailed the efficiency of cross-functional collaboration in their organisation.
Phillips-Medisize, a Molex company and specialist in the design and manufacture of drug delivery, diagnostic and medtech devices, has expanded its product portfolio with the introduction of a disposable pen injector.
Airnov Healthcare Packaging, a provider in controlled atmosphere packaging, has launched a brand-new advanced solution which promises to provide substantial benefits to the pharmaceutical industry.
